NXPH4 and neoplasm: Conversely, overexpressing NXPH4 significantly enhanced organoid growth, and these findings were validated in vivo by implanting cells with stable NXPH4 downregulation subcutaneously, thereby confirming our earlier observation of reduced tumor cell proliferation upon NXPH4 silencing (Fig. 2Q–S).